JP Morgan Call 86 JCI 17.04.2025/ DE000JT89977 /
15.11.2024 9:38:16 | Изменение-0.070 | Бид22:00:29 | Предложение22:00:29 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.790EUR | -8.14% | - Величина цены спроса: - |
- Величина цены предложения: - |
Johnson Controls Int... | 86.00 USD | 17.04.2025 | Call |
GlobeNewswire
25.07
Genetec announces successful outcome over Sensormatic’s patent infringement claims
GlobeNewswire
29.12.2023
Visionary Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its ...
GlobeNewswire
13.12.2023
Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors
GlobeNewswire
12.12.2023
LAX’s Rent-A-Car facility recognized for sustainability excellence by U.S. Green Business Council–Lo...
GlobeNewswire
02.11.2023
Applied UV Inc. Secures New Patent Approval From the USPTO for Interchangeable Drain Disinfecting De...
GlobeNewswire
30.10.2023
Applied UV Inc. Granted Significant New Patents by USPTO and Enters Into Strategic Partnership With ...
GlobeNewswire
25.10.2023
The most disruptive and sustainable construction meets at Tomorrow.Building World Congress
Newsfile Corp
12.09.2023
UL Solutions Joins the ISASecure Program in Support of ISA/IEC 62443 Cybersecurity Conformance
GlobeNewswire
28.03.2022
SAITECH Joins Two International District Heating Associations: Euroheat & Power (EHP) and The Intern...
GlobeNewswire
24.02.2022
Apollo Launches Sustainable Investing Platform, Sees the Opportunity to Deploy More Than $100 Billio...
GlobeNewswire
23.02.2022
Beam Global Announces Strategic Acquisition of AllCell Technologies, a Leader in Energy Storage Solu...
GlobeNewswire
09.02.2022
RegScale and Carahsoft Partner to Deliver Compliance Automation to the Public Sector
GlobeNewswire
10.01.2022
Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница